BR9709993A - Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica - Google Patents
Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênicaInfo
- Publication number
- BR9709993A BR9709993A BR9709993A BR9709993A BR9709993A BR 9709993 A BR9709993 A BR 9709993A BR 9709993 A BR9709993 A BR 9709993A BR 9709993 A BR9709993 A BR 9709993A BR 9709993 A BR9709993 A BR 9709993A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- immunogenic
- vaccine
- antigen
- production
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 6
- 230000002163 immunogen Effects 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201766 | 1996-06-25 | ||
| PCT/NL1997/000354 WO1997049425A1 (en) | 1996-06-25 | 1997-06-24 | Vaccine comprising antigens bound to carriers through labile bonds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9709993A true BR9709993A (pt) | 1999-08-10 |
Family
ID=8224113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9709993A BR9709993A (pt) | 1996-06-25 | 1997-06-24 | Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0912195B1 (pt) |
| JP (1) | JP4651753B2 (pt) |
| AT (1) | ATE421331T1 (pt) |
| AU (1) | AU732085B2 (pt) |
| BR (1) | BR9709993A (pt) |
| CA (1) | CA2260761C (pt) |
| DE (1) | DE69739233D1 (pt) |
| DK (1) | DK0912195T3 (pt) |
| NZ (1) | NZ333562A (pt) |
| WO (1) | WO1997049425A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6846968B1 (en) | 1988-02-26 | 2005-01-25 | Large Scale Biology Corporation | Production of lysosomal enzymes in plants by transient expression |
| US5907030A (en) | 1995-01-25 | 1999-05-25 | University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
| KR100691315B1 (ko) * | 1996-09-26 | 2007-03-12 | 유니버시티 오브 써던 캘리포니아 | 친수성 분자를 지질화시키기 위한 방법 및 조성물 |
| GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
| US6730306B1 (en) * | 2000-03-08 | 2004-05-04 | Large Scale Biology Corporation | Parvovirus vaccine as viral coat protein fusions |
| ATE409495T1 (de) | 2001-04-04 | 2008-10-15 | Nordic Vaccine Technology As | Polynukleotide-bindende komplexe die sterolen und saponine enthalten |
| US20060052592A1 (en) * | 2002-06-20 | 2006-03-09 | Levinson Arnold I | Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| WO2010057251A1 (en) * | 2008-11-18 | 2010-05-27 | The University Of Queensland | Peptide conjugates for suppressing an immune response, methods of making and uses therefor |
| WO2011123042A1 (en) * | 2010-04-01 | 2011-10-06 | Independent Pharmaceutica Ab | Vaccination procedure and products for use therein |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3937412A1 (de) | 1989-11-10 | 1991-05-16 | Hoechst Ag | Synthetische vakzine zur spezifischen induktion zytotoxischer t-lymphozyten |
| NL8900726A (nl) * | 1989-03-23 | 1990-10-16 | Stichting Centr Diergeneeskund | Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens. |
| US5256641A (en) | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
| EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
| DE4101394A1 (de) * | 1991-01-18 | 1992-07-23 | Medor Lab Fuer Biochemie Und K | Verfahren zum koppeln von kohlenhydraten an traeger, insbesondere proteine |
| DE69230855D1 (de) * | 1991-07-26 | 2000-05-04 | Commw Scient Ind Res Org | System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung |
| US5785974A (en) * | 1993-01-23 | 1998-07-28 | Immunologia Y Genetica Aplicada, S.A. | Synthetic peptides and vaccines against parvovirus |
| JP3795914B2 (ja) * | 1993-04-27 | 2006-07-12 | ユナイテッド・バイオメディカル・インコーポレイテッド | ワクチン用免疫原性ｌｈｒｈペプチド構築体および合成普遍免疫刺激器 |
| AU678613B2 (en) | 1993-09-22 | 1997-06-05 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
-
1997
- 1997-06-24 NZ NZ333562A patent/NZ333562A/en not_active IP Right Cessation
- 1997-06-24 JP JP50272998A patent/JP4651753B2/ja not_active Expired - Fee Related
- 1997-06-24 AT AT97927484T patent/ATE421331T1/de active
- 1997-06-24 CA CA2260761A patent/CA2260761C/en not_active Expired - Fee Related
- 1997-06-24 AU AU31938/97A patent/AU732085B2/en not_active Ceased
- 1997-06-24 DE DE69739233T patent/DE69739233D1/de not_active Expired - Lifetime
- 1997-06-24 WO PCT/NL1997/000354 patent/WO1997049425A1/en not_active Ceased
- 1997-06-24 EP EP97927484A patent/EP0912195B1/en not_active Expired - Lifetime
- 1997-06-24 BR BR9709993A patent/BR9709993A/pt not_active Application Discontinuation
- 1997-06-24 DK DK97927484T patent/DK0912195T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2260761A1 (en) | 1997-12-31 |
| DK0912195T3 (da) | 2009-05-18 |
| ATE421331T1 (de) | 2009-02-15 |
| DE69739233D1 (de) | 2009-03-12 |
| NZ333562A (en) | 2001-04-27 |
| JP4651753B2 (ja) | 2011-03-16 |
| CA2260761C (en) | 2011-05-03 |
| AU3193897A (en) | 1998-01-14 |
| EP0912195B1 (en) | 2009-01-21 |
| AU732085B2 (en) | 2001-04-12 |
| WO1997049425A1 (en) | 1997-12-31 |
| EP0912195A1 (en) | 1999-05-06 |
| JP2000513353A (ja) | 2000-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000020027A3 (en) | Methods for therapeutic vaccination | |
| WO1995029193A3 (en) | Melanoma antigens | |
| BR9306820A (pt) | Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero | |
| BRPI0314373B8 (pt) | produto imunogênico estável para a indução de anticorpos contra uma ou várias proteínas antigênicas em um indivíduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
| ATE318899T1 (de) | Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort | |
| WO2002072036A3 (en) | Compositions and methods comprising west nile virus polypeptides | |
| US20180104322A1 (en) | Immunogenic composition for use in therapy | |
| BR9709993A (pt) | Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica | |
| WO2003088995A3 (en) | Mucin fusion polypeptide vaccines, compositions and methods of use thereof | |
| BR0111834A (pt) | Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno | |
| ATE370745T1 (de) | Verbesserte polysaccharid- und glykokonjugat- vakzine | |
| DE69534382D1 (de) | Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind | |
| WO2003059379A3 (en) | Immunogenic carcinoembryonic antigen (cea) | |
| Coughlin et al. | Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines | |
| Lövgren-Bengtsson et al. | The ISCOM™ technology | |
| CY1106252T1 (el) | Εμβολιο πολλαπλων συστατικων που πepιλαμβανει τουλαχιστον δυο αντιγονα απο haemophilus influenzae για την προστασια εναντι νοσησης | |
| US6956119B2 (en) | Polysaccharide-polypeptide conjugate | |
| KR890000106A (ko) | 원생성 기생충 예방용 백신 | |
| PL331792A1 (en) | Aviadenovirus, nucleic acid sequence encoding an antigen determinant, host cell transformed by such sequence, antibody or immune serum reacting with such antigen determinant and vaccine against diseases associated with a novel adenovirus | |
| IT1226728B (it) | Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso | |
| WO2002085409A3 (en) | Methods and compositions for inducing an immune response to an antigen | |
| Opuda-Asibo | Expression of humoral immunologic mechanisms against Pasteurella haemolytica in the bovine lung. | |
| AU2019202649A1 (en) | Method of treatment | |
| YU24401A (sh) | Novi postupci za terapeutsku vakcinaciju |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |